Author:
Chase Maureen,Chung Richard Y.,Chiocca E. Antonio
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference38 articles.
1. Martuza, R.L., Malick, A., Markert, J.M., Ruffner, K.L. and Coen, D.M. 1991. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252: 854–856.
2. Mineta, T., Rabkin, S.D., Yazaki, T., Hunter, W.D. and Martuza, R.L. 1995. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat. Med. 1: 938–943.
3. Boviatsis, E.J., Park, J.S., Sena-Esteves, M., Kramm, C., Chase, M., Efird, J. et al. 1994. Long-term survival of rats harboring brain tumors treated with ganci-clovir and a herpes simplex virus vector that maintains an intact thymidine kinase gene. Cancer Res. 54: 5745–5751.
4. Chambers, R., Gillespie, G.Y., Soroceanu, L., Andreasky, S., Chatterjee, J., Chou, J. et al. Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. Proc. Natl. Acad. Sci. USA 92: 1411–1415 1995.
5. Pyles, R.B., Wamfck, R.E., Chalk, C.L., Szanti, B.E. and Parysek, L.M. A novel multiply-mutated HSV-1 strain for the treatment of brain tumors. Hum. Gen. Ther. 8: 533–544 1997.
Cited by
156 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献